Excision Repair Cross-Complementation Group 6 Gene Polymorphism Is Associated with the Response to FOLFIRINOX Chemotherapy in Asian Patients with Pancreatic Cancer

SIMPLE SUMMARY: FOLFIRINOX is a platinum-based chemotherapy regimen for patients with pancreatic cancer and is known to be more effective in the presence of the BRCA mutation, one of the DNA damage repair (DDR) gene mutations. However, BRCA mutations are less common in pancreatic cancer patients, ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Young Hoon, Lim, Younggyun, Ryu, Ji Kon, Paik, Woo Hyun, Lee, Sang Hyub, Kim, Yong-Tae, Kim, Ju Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998301/
https://www.ncbi.nlm.nih.gov/pubmed/33801891
http://dx.doi.org/10.3390/cancers13061196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998301/
https://www.ncbi.nlm.nih.gov/pubmed/33801891
http://dx.doi.org/10.3390/cancers13061196

Ejemplares similares